UCB Scientific & Medical Information

For important information on coronavirus (COVID-19) and the use of CIMZIA® (certolizumab pegol), click here. To learn more about UCB’s preparedness, read the UCB Statement on COVID-19 Outbreak.

Your gateway to scientific education and clinical information on UCB medicines used to treat patients suffering from certain immunologic disorders

Unlock Additional Features

Create Account

Already have an account? Sign In

Quickly access recent
medical and scientific
information

Save content to
your personal
library

Receive update
alerts on content of
interest

Create Account

Already have an account? Sign In

Scientific Congresses

Access UCB-sponsored scientific data
presentations from recent congresses.

See the Latest

Medical Information

Search our database for the most recent
medical information on UCB products.

Search for Information

MSL Connect

Find a field-based UCB Medical Science Liaison (MSL) in your region.

Find MSL

Podcasts

See all Podcasts

Listen

Joint Perspectives

Listen

Videos

See all Videos

New Frontiers in Psoriasis

Evolving pathogenesis, treatment goals and patient expectations

Watch Video

axSpA, PsA

The Evolving Pathobiology of Axial Spondyloarthritis and Psoriatic Arthritis

PsO

Eleventh International Immunology Summit: Holistic Care in Psoriatic Disease: What Does it Mean and is it Possible?

PsA

Eleventh International Immunology Summit: Is Minimal Disease Activity Good Enough?

Our Science

See Clinical Trials Section

Clinical Trials

Browse UCB-sponsored clinical trials
by status, condition, or intervention.

Search Clinical Trials

Opportunities for Investigators

Submit a study concept or request access to patient-level
data and supporting documents from UCB trials.

Learn More